This firm fixed-price purchase order awards Psomagen Inc. $422,000 to provide RNA sequencing services to the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), from June 2021 through June 2023. The contract supports NIA research on Alzheimer's disease and related dementias by requiring the contractor to construct sequencing libraries from 20 human samples, perform sequencing on an Illumina NovaSeq 6000 platform, and deliver various data files. No set-aside...
This is a $3,849,800.00 firm fixed-price purchase order contract awarded to Psomagen Inc., a small business, by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH). The contract is for neurodegenerative disease research, including whole genome sequencing services, with a completion date of September 14, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and is a provider of genomic sequencing, bioinformatics, and related services to federal government...
This is a $206,250 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is for total RNA sequencing services, with an option to increase the value. The awardee is Psomagen Inc., a for-profit manufacturer of genomics and molecular biology services based in Rockville, Maryland. This contract does not have a set-aside designation. Psomagen is...
This firm-fixed price purchase order for $600,000 was awarded by the National Institute on Aging, a component of the National Institutes of Health within the Department of Health and Human Services, to Psomagen, Inc. for whole genome sequencing services. Under the terms of the contract, Psomagen will sequence 1,000 human samples to 30x coverage using Illumina sequencing technologies and deliver raw sequencing data files within 4-6 weeks. The work will be performed in Potomac, Maryland over a one...
This federal contract award is for $313,500.00 in single cell multiome sequencing services, provided by Psomagen Inc., a subsidiary of Macrogen, Inc. The contract was awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH). The contract is a firm fixed price purchase order with a period of performance through March 1, 2026. Psomagen Inc. is a prime contractor that specializes in delivering a wide range of genomic and molecular biology...
This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract, valued at $4,942.00, is for DNA sequencing services. It is not a set-aside contract. The contract supports NIAID's research efforts, potentially including work on neurodegenerative diseases, cancer, and infectious diseases. Psomagen has previously received...
This is a firm-fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Psomagen Inc., a wholly-owned subsidiary of Macrogen, Inc. The contract ceiling value is $9,999.30 and it is for DNA sequencing services. The contract is not set aside for any specific business category. Psomagen Inc. is a leading provider of genomic and molecular biology services to federal agencies, including the National Institutes of Health (NIH), U.S. Department...
<p>The National Institutes of Health National Institute on Aging awarded a $288,900.00 purchase order to Psomagen Inc., a subsidiary of Macrogen, Inc., to provide single cell multiome sequencing services from July 3, 2023 through July 2, 2024. The firm fixed price contract will support Psomagen in conducting single cell multiome sequencing at its facility located in Potomac, Maryland to assist the National Institutes of Health National Institute on Aging in advancing biomedical research.</p>
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $10,000.00 firm fixed-price purchase order is for DNA sequencing services. The contract has no set-aside designation. Psomagen Inc. is a provider of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, that supports...
This federal contract award, valued at $44,940.00, was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a for-profit manufacturer of genomic sequencing and bioinformatics services. The contract is for "SEQUENCING NOVASEQX 25B 150PE, FLOW CELL" and has a firm fixed-price structure with a completion date of November 16, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and has...